Ground News

institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Managed Healthcare Executive image

News from Managed Healthcare Executive

All of today’s top news stories from Managed Healthcare Executive. Get the full analysis behind how media bias impacts breaking news.

We’ve discovered 377 headlines written by Managed Healthcare Executive during the past 3 months.

Managed Healthcare Executive’s media bias is unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check.

Managed Healthcare Executive’s aggregated factuality score is Unknown. Factuality is assigned by combining fact check, credibility, and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about Managed Healthcare Executive

Where is Managed Healthcare Executive located?Managed Healthcare Executive's Website

Media Bias Ratings

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Managed Healthcare Executive News

Louisiana Lawmakers React to House Passing the 'Big, Beautiful Bill'

Louisiana Lawmakers React to House Passing the 'Big, Beautiful Bill'

65% Center coverage: 35 sources

Louisiana lawmakers are reacting to the House passing President Donald Trump's "big, beautiful bill."See the Story

With FDA Nod in Lung Cancer, Dizal Now Aims to Best a J&J Drug and Succeed Where Takeda Fell Short

Johnson & Johnson · United States

With FDA Nod in Lung Cancer, Dizal Now Aims to Best a J&J Drug and Succeed Where Takeda Fell Short

71% Center coverage: 32 sources

Dizal Pharmaceutical’s Zegfrovy is now FDA approved for treating non-small cell lung cancer driven by a particular rare genetic signature. Johnson & Johnson drug Rybrevant already addresses this genetic signature as an earlier line of therapy, but Dizal executives contend their drug offers the potential for better safety and efficacy. The post With FDA Nod in Lung Cancer, Dizal Now Aims to Best a J&J Drug and Succeed Where Takeda Fell Short appe…See the Story

Long-Term Exposure to Air Pollution Associated with Early Signs of Heart Damage

Pollution · Schenectady

Long-Term Exposure to Air Pollution Associated with Early Signs of Heart Damage

60% Center coverage: 15 sources

Researchers using cardiac MRI have found that long-term exposure to air pollution is associated with early signs of heart damage, according to a study that was published today in Radiology, a journal of the Radiological Society of North America (RSNA).See the Story

Blindspots

RFK Jr., Dr. Oz pledge to reform prior authorization of major health insurers

Low coverage from Left Sources

RFK Jr., Dr. Oz pledge to reform prior authorization of major health insurers

'These Funds Keep People Alive': HIV Prevention Funding at Risk

Low coverage from Right Sources

'These Funds Keep People Alive': HIV Prevention Funding at Risk

New Bispecific T-Cell Engager Approved for Multiple Myeloma

83% Center coverage: 6 sources

(MedPage Today) -- The FDA on Wednesday granted accelerated approval to linvoseltamab (Lynozyfic) for relapsed or refractory multiple myeloma after at least four prior lines of therapy. A B-cell maturation antigen (BCMA)-directed bispecific antibody...Cancer · United States See the Story

HPV Cancer Burden by Anatomical Site, Country, and Region in 2022

Coverage: 2 sources

HPV vaccination can prevent more than 90% of HPV infection-related cancers. Understanding the epidemiological burden of HPV-related cancers can better promote HPV vaccination and HPV-based screening programs. We used three databases—Global Burden of Disease 2021 (GBD2021), Global Cancer Observatory 2022 (GLOBOCAN2022), and Cancer Incidence in Five Continents Plus (CI5Plus)—to evaluate the global disease burden of cervical cancer, penile cancer, …Cancer See the Story

Adding Imfinzi to FLOT Regimen Improves Cancer-Free Survival in Patients with Gastroesophageal Cancer

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.Read Article

Study Shows Nerandomilast Slowed Lung Function Decline in Progressive Pulmonary Fibrosis

Results come after positive results from a trial among people with idiopathic pulmomary disease.Spain · Spain See the Story

Health Systems Race to Secure Expert Guidance as Medicaid Budget Cuts Loom - Black Book Flash Poll – RamaOnHealthcare

Legislative Threats to Medicaid Funding Drive 300+ Vulnerable Hospitals to Reevaluate Financial Resilience, Operations, and Community ImpactWASHINGTON,United States · United States See the Story

Study Insights: Exploring Healthcare Utilization in T1D

Panelists discuss how their study compared healthcare resource utilization between newly diagnosed patients with type 1 diabetes with and without prior type 2 diabetes misdiagnosis, using a retrospective claims database analysis to examine utilization patterns across different healthcare services.Read Article

The Future of Duchenne Muscular Dystrophy Treatment: Expert Insights on Gene Therapy

A panelist discusses how ongoing research into next-generation DMD therapies aims to improve delivery methods, develop better vectors that can carry larger dystrophin genes, and determine optimal treatment timing, with evidence suggesting earlier intervention may be more effective.See the Story

Dialysis Industry Is Now the Most Concentrated in Healthcare, Study Finds, With Prices Far Higher in Monopoly Areas – RamaOnHealthcare

Physician ownership of facilities and joint ventures with major chains also increased substantially from 2005 to 2019.With the two largest dialysis chains, DaVita Inc. and Fresenius Medical Care, now owning nearly 80% of facilities in the United States, academics, advisory groups and regulators have all called for an analysis of the industry’s growing consolidation, including [...]Healthcare · United States See the Story

Breaking News Topics Related to Managed Healthcare Executive